MT. KISCO, N.Y., Dec. 10, 2015 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) today announced that it has engaged One Equity Research LLC ("One Equity") to provide advisory services and research covering milestone or inflection points in the Company's development.
One Equity has built a robust network that enables them to reach tens of thousands of highly-targeted investors with a high-affinity for undervalued growth companies. ImmuDyne believes this visibility will benefit the Company's growth and vision for the future.
So where are the "tens of thousands" of "investors with a high-affinity for undervalued growth companies."?
Is this another McLaughlin debacle? IMMD has great products, with the most potent patented processes, in a market that is growing. Yet, he fails to deliver. There is no evidence of increased investor interest and the stock price is stuck. Get the I.R. program going or get someone who can!
